Business
OrthoPediatrics’ ApiFix® System Selected as 2022 MDEA Finalist
WARSAW, Indiana, April 06, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused
About this update from Orthopediatrics Corp.
[{"type":"text","content":"WARSAW, Indiana, April 06, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that the ApiFix® System has been named a category finalist for the 2022 Medical Design Excellence Awards (MDEA), the premier design awards program for the medical technology industry. Entries are judged by an impartial panel of MedTech experts, including practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. MDEA jurors comprehensively review entries based on the following criteria: the ability of the product development team to overcome all challenges so the product meets its clinical objectives; innovative use of materials, components, and processes; user-related functions improving healthcare delivery and changing traditional medical attitudes or practices; features providing enhanced benefits to the patient and end-user in relation to clinical efficacy; manufacturing cost-effectiveness and profitability; and healthcare system benefits such as improved accessibility, efficacy, or safety, in addition to providing attention to a critical unmet clinical need. “We are delighted and honored to be named a finalist for MDEA,” said Kimber Chang, Global Marketing Manager of Scoliosis for OrthoPediatrics. “This recognition embodies the dedication and passion of our international team members and surgeon partners who are committed to providing children with a new treatment pathway for adolescent idiopathic scoliosis that otherwise would not exist in the non-fusion space.” The ApiFix procedure offers select adolescent idiopathic scoliosis (“AIS”) patients a less invasive, motion-preserving option for achieving curve correction – without the permanence of fusion. The ApiFix system’s novel approach to correcting spinal deformity is a welcome medical advancement that has the ability to disrupt the continuum of care for scoliosis treatment in certain pediatric patients. Its elegant design and biomechanical considerations combined with the simplistic posterior approach is unmatched. ApiFix‘s unique technology is supported by numerous issued patents and pending patent applications worldwide. Entries are scored based on five criteria: Design and E...